BioSpace News Archive

A clinical trial is a process carried out to ascertain the effectiveness and safety of a pharmaceutical preparation.

The global narcolepsy market is anticipated to witness moderate growth during the forecast period between 2021 and 2031.

Single-cell genome sequencing involves isolating a single cell and amplifying and sequencing genes within that single cell.

Technologies and techniques in global gene synthesis market are methods in synthetic biology.

The oncology small molecule drugs market is prophesied to display phenomenal growth and outperform other available drug therapies for the treatment of cancer in the forthcoming years.

The global DNA probes-based diagnostics market is expected to witness robust growth in the forthcoming years.

SeqLL Inc. announced a new study demonstrating early cancer detection using SeqLL’s single-molecule technology was published in the peer-reviewed journal Nature Biotechnology.

Susan G. Komen®, the world’s leading breast cancer organization, will hold an in-person MORE THAN PINK Walk in San Francisco to raise critical funds that support breast cancer research and breast cancer patients who are in need of financial assistance.

Nine Square Therapeutics, a biotechnology company applying computational chemistry and machine-learning enabled cell profiling to discover and develop novel small-molecule therapeutics for life-threatening neurodegenerative diseases, such as Parkinson’s disease and ALS, announced today that John Hood, Ph.D., has joined the company’s Board of Directors.

Prague, Czech Republic, September 13th, 2022. CasInvent Pharma, an early-stage drug discovery company developing small-molecule compounds with anticancer properties, has raised a follow-up investment round of €1.3 million provided by KHAN Technology Transfer Fund I (KHAN-I) and i&i Biotech Fund (i&i Bio).